Fibrinolytic changes and the influence of the early perfusate in orthotopic liver transplantation with intraoperative aprotinin treatment.
Himmelreich
G
G
Department of Internal Medicine, Universitätsklinikum Rudolf Virchow, Berlin, Germany.
Kierzek
B
B
Neuhaus
P
P
Slamer
K J
KJ
Riess
H
H
D000990:Antithrombin III / Q000378:metabolism; D007611:Aprotinin / Q000627:therapeutic use*; D001777:Blood Coagulation; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D016031:Liver Transplantation / Q000379:methods*; D010477:Perfusion; D015849:Plasminogen Inactivators / Q000378:metabolism; D011486:Protein C / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D015849:Plasminogen Inactivators; D011486:Protein C; D000990:Antithrombin III; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator